The drug HEPATOXANE contains one active pharmaceutical ingredient (API):
Anethole trithione is a bile secretion-stimulating drug that restores salivation and relieves the discomfort of dry mouth in chemotherapy-induced xerostomia. In addition, this agent has exhibited chemopreventive properties. The mechanism of action to these activities have yet to be formally elucidated.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
This brand name is authorized in the following countries: Hong Kong
This drug has been assigned below unique identifiers within the countries it is being marketed: